, is proud to announce that MLS manufactured an H1N1 influenza A challenge stock for Immune Targeting Systems, Ltd. Immune Targeting Systems contracted Meridian Life Science to manufacture the ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com TORRANCE, Calif., March 06, 2024 (GLOBE ...
Jack Kenny, Chief Executive Officer, commented, “As we begin the transition into a post-COVID world, we have significant optimism for the future of Meridian. Life Science was transformed by the ...
MINNEAPOLIS, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Pace ® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace ® Science and Technology ...
CINCINNATI, April 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that eliminates ...
100% technical buy signals. 8 new highs and up 15.79% in the last month. 42.69% gain in the last year. Morsa Images/DigitalVision via Getty Images The Chart of the Day belongs to the diagnostics and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meridian Bioscience has made ...
New formats redefine molecular assay development by cutting refrigeration costs, simplifying logistics, and ensuring uncompromised performance at room temperature. For decades, the molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback